MUCO Mepha cpr eff 200 mg bte 30 pce
7680523850165
CH-52385
R05CB01
03.02.0.
1 / 2
google
Details
- Product number
- 5238501
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- acetylcysteinum 200 mg, acidum citricum, natrii hydrogenocarbonas corresp. natrium 190.5 mg, povidonum K 25, acidum adipicum, aspartamum 20 mg, aromatica (Zitrone) cum saccharum, pro compresso.
Articles (1)
Muco-Mepha 200 mg, Brausetabletten
Brausetabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
acetylcysteinum
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
acidum citricum
|
- | Substance | HNIDK |
|
natrii hydrogenocarbonas
|
- | Substance | HNIDK |
|
natrium
|
190.5 MG | Substance | HBESI |
|
povidonum K 25
|
- | Substance | HNIDK |
|
acidum adipicum
|
- | Substance | HNIDK |
|
aspartamum
|
20.0 MG | Substance | HBESI |
|
aromatica
|
- | Substance | AROMA |
|
saccharum
|
- | Substance | HBESI |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 52385
- Drug name
- Muco-Mepha, Brausetabletten
- Galenic form
- BRAT
- ATC Code
- R05CB01
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 25/02/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 03.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MUCO Mepha cpr eff 200 mg bte 30 pce
- Description (DE)
- MUCO Mepha Brausetabl 200 mg Ds 30 Stk
- Market launch
- 25/02/1994
- Market withdrawal
- 22/06/2026
- Narcotic (BTM)
- No